Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia

被引:412
作者
Blum, AL [1 ]
Talley, NJ
O'Moráin, C
van Zanten, SV
Labenz, J
Stolte, M
Louw, JA
Stubberöd, A
Theodórs, A
Sundin, M
Bolling-Sternevald, E
Junghard, O
机构
[1] CHU Vaudois, Div Gastroenterol, CH-1011 Lausanne, Switzerland
[2] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia
[3] Nepean Hosp, Sydney, NSW, Australia
[4] Trinity Coll Dublin, Meath Hosp, Dept Gastroenterol, Dublin, Ireland
[5] Trinity Coll Dublin, Adelaide Hosp, Dept Gastroenterol, Dublin, Ireland
[6] Queen Elizabeth 2 Hlth Sci Ctr, Div Gastroenterol, Halifax, NS, Canada
[7] Univ Klin Otto von Guericke, Magdeburg, Germany
[8] Klinikum Bayreuth, Inst Pathol, Bayreuth, Germany
[9] Univ Cape Town, Dept Gastroenterol, ZA-7925 Cape Town, South Africa
[10] Groote Schuur Hosp, ZA-7925 Cape Town, South Africa
[11] Varnamo Hosp, Dept Surg, Varnamo, Sweden
[12] St Josphs Hosp, Div Gastroenterol, Hafnarfjordur, Iceland
[13] Astra Hassle AB, Dept Clin Res, Molndal, Sweden
[14] Astra Hassle AB, Dept Stat, Molndal, Sweden
[15] Linkoping Hosp, Dept Biomed & Surg, Linkoping, Sweden
关键词
D O I
10.1056/NEJM199812243392602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background It is uncertain whether treatment of Helicobacter pylori infection relieves symptoms in patients with nonulcer, or functional, dyspepsia. Methods We conducted a double-blind, multicenter trial of patients with H. pylori infection and dyspeptic symptoms (moderate-to-very-severe pain and discomfort centered in the upper abdomen). Patients were excluded if they had a history of peptic ulcer disease or gastroesophageal reflux disease and had abnormal findings on upper endoscopy. Patients were randomly assigned to seven days of treatment with 20 mg of omeprazole twice daily, 1000 mg of amoxicillin twice daily, and 500 mg of clarithromycin twice daily or with omeprazole alone and then followed up for one year. Treatment success was defined as the absence of dyspeptic symptoms or the presence of minimal symptoms on any of the 7 days preceding the 12-month visit. Results Twenty of the 348 patients were excluded after randomization because they were not infected with H. pylori, were not treated, or had no data available. For the remaining 328 patients (164 in each group), treatment was successful for 27.4 percent of those assigned to receive omeprazole and antibiotics and 20.7 percent of those assigned to receive omeprazole alone (P = 0.17; absolute difference between groups, 6.7 percent; 95 percent confidence interval, -2.6 to 16.0). After 12 months, gastritis had healed in 75.0 percent of the patients in the group given omeprazole and antibiotics and in 3.0 percent of the patients in the omeprazole group (P<0.001); the respective rates of H. pylori eradication were 79 percent and 2 percent. In the group given omeprazole and antibiotics, the rate of treatment success among patients with persistent H. pylori infection was similar to that among patients in whom the infection was eradicated (26 percent vs. 31 percent). There were no significant differences between the groups in the quality of life after treatment. Conclusions In patients with nonulcer dyspepsia, the eradication of H. pylori infection is not likely to relieve symptoms. (N Engl J Med 1998;339:1875-81.) (C) 1998, Massachusetts Medical Society.
引用
收藏
页码:1875 / 1881
页数:7
相关论文
共 31 条
  • [1] Agresti A., 1996, An introduction to categorical data analysis
  • [2] Helicobacter pylori infection and dyspepsia
    Armstrong, D
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 : 38 - 47
  • [3] IS HELICOBACTER-PYLORI THE CAUSE OF DYSPEPSIA
    BERNERSEN, B
    JOHNSEN, R
    BOSTAD, L
    STRAUME, B
    SOMMER, AI
    BURHOL, PG
    [J]. BRITISH MEDICAL JOURNAL, 1992, 304 (6837) : 1276 - 1279
  • [4] Blum AL, 1997, GASTROENTEROLOGY, V112, pA73
  • [5] Diagnosing dyspepsia: Any controversies left?
    Bytzer, P
    [J]. GASTROENTEROLOGY, 1996, 110 (01) : 302 - 306
  • [6] WELL-BEING AND GASTROINTESTINAL SYMPTOMS AMONG PATIENTS REFERRED TO ENDOSCOPY OWING TO SUSPECTED DUODENAL-ULCER
    DIMENAS, E
    GLISE, H
    HALLERBACK, B
    HERNQVIST, H
    SVEDLUND, J
    WIKLUND, I
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 (11) : 1046 - 1052
  • [7] QUALITY-OF-LIFE IN PATIENTS WITH UPPER GASTROINTESTINAL SYMPTOMS - AN IMPROVED EVALUATION OF TREATMENT REGIMENS
    DIMENAS, E
    GLISE, H
    HALLERBACK, B
    HERNQVIST, H
    SVEDLUND, J
    WIKLUND, I
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 (08) : 681 - 687
  • [8] Classification and grading of gastritis - The updated Sydney System
    Dixon, MF
    Genta, RM
    Yardley, JH
    Correa, P
    Batts, KP
    Dahms, BB
    Filipe, MI
    Haggitt, RC
    Haot, J
    Hui, PK
    Lechago, J
    Lewin, K
    Offerhaus, JA
    Price, AB
    Riddell, RH
    Sipponen, P
    Solcia, E
    Watanabe, H
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) : 1161 - 1181
  • [9] A citric acid solution is an optimal test drink in the C-13-urea breath test for the diagnosis of Helicobacter pylori infection
    DominguezMunoz, JE
    Leodolter, A
    Sauerbruch, T
    Malfertheiner, P
    [J]. GUT, 1997, 40 (04) : 459 - 462
  • [10] Reinfection and duodenal ulcer relapse in South-East Asian patients following successful Helicobacter pylori eradication: Results of a 2-year follow-up
    Goh, KL
    Navaratnam, P
    Peh, SC
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (12) : 1157 - 1160